Chinese venture capital firm Qiming Venture Partners has led a US$20 million financing round in New Horizon Health, a Chinese precision health start-up focused on developing early-stage cancer screening technologies.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
